SV Health Investors svhealthinvestors.com

SV Health Investors - Key People

Name Bio Twitter
Michael BalmuthMichael joined SVLS in 2014 and is focused on healthcare IT and healthcare services investments. Before joining SVLS, Michael was a General Partner with Edison Ventures, a growth equity investment firm, where he headed the healthcare IT practice. P show more…
Kate BinghamKate Bingham joined SVLS in 1991. Kate currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Alantos, Auxilium, ESBATech, Hexagen, Kinetix, KuDOS, Leuko show more…
Graham BoulnoisProfessor Graham Boulnois joined SVLS as a Venture Partner in 2001 and became a Partner in 2004. Graham is a Director of Delanex, Oxagen,Affinium and Vantia. He has responsibility for overseeing the investment in Cellzome. He was a Director at Lorant show more…
Daniel BurgessDaniel Burgess joined SV Life Sciences as a Venture Partner in 2014. Prior to joining SV, Mr. Burgess was founder, President and CEO of Rempex Pharmaceuticals, Inc. (SVLS Fund V), an antibiotic company that was sold to the Medicines Company two yea show more…
Hamish CameronDr Hamish Cameron joined SVLS in 2008 as a Venture Partner and became an Operating Partner in 2014. He has been Interim CEO at X2-Pharma, Delenex Therapeutics and TopiVert Pharma and Chief Commercial Officer at ESBATech. He is currently a Director a show more…
See all 23 people